Modular in vivo antibody–ADC click to reverse drug resistance in tumours - Nature

In vivo ligation of clinically used therapeutic antibodies via bioorthogonal click chemistry to antibody–drug conjugates leads to enhanced antitumour activity in heterogeneous and treatment-resistant tumours.

Raccontata danature.com